HIPK2 and chronic kidney disease: SIRT6 is demonstrated to protect the liver from fibrosis induced by deregulated HSCs [120,121], and SIRT6 overexpression has been shown to inhibit HIPK2 at the protein level with a reduction in renal interstitial fibrosis and renal function deterioration in CKD [73].